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Abstract  
Mineralocorticoid Receptor (MR) expression is increased in adipose tissue from obese individuals and 
animals. We previously demonstrated that adipocyte-MR over-activation in mice (Adipo-MROE) is 
associated with metabolic changes. Whether adipocyte-MR directly influences vascular function in 
these mice is unknown. We tested this hypothesis in resistant mesenteric arteries from Adipo-MROE 
using myography and in cultured adipocytes. Molecular mechanisms were probed in vessels/vascular 
smooth muscle cells and adipose tissue/adipocytes and focused on redox-sensitive pathways, Rho 
kinase activity and protein kinase G type-1 (PKG-1) signaling. Adipo-MROE versus Control-MR 
mice exhibited reduced vascular contractility, associated with increased generation of adipocyte-
derived hydrogen peroxide, activation of vascular redox-sensitive PKG-1 and downregulation of Rho 
kinase activity. Associated with these vascular changes was increased elastin content in Adipo-
MROE. Inhibition of PKG-1 with Rp-8-Br-PET-cGMPS normalized vascular contractility in Adipo-
MROE. In the presence of adipocyte conditioned culture medium, anticontractile effects of the 
adipose tissue were lost in Adipo-MROE, but not in Control-MR mice. In conclusion, adipocyte-MR 
upregulation leads to impaired contractility with preserved endothelial function and normal blood 
pressure. Increased elasticity may contribute to hypocontractility. We also identify functional 
crosstalk between adipocyte-MR and arteries and describe novel mechanisms involving redox-
sensitive PKG-1 and Rho kinase. Our results suggest that adipose tissue from Adipo-MROE secrete 
vasoactive factors that preferentially influence VSMCs rather than endothelial cells. Our findings may 
be important in obesity/adiposity where adipocyte-MR expression/signaling is amplified and vascular 
risk increased. 
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Non-standard Abbreviations and Acronyms 
ACh   acetylcholine 
ACM   adipocyte conditioned culture medium 
Adipo-MROE  adipocyte MR overexpression 
eNOS   endothelial nitric oxide synthase 
ERM   ezrin-radixin-moesin proteins 
EVAT   epididymal visceral adipose tissue 
H2O2   hydrogen peroxide 
IRS1   insulin receptor substrate 1 
MLC   myosin light chain 
MR   mineralocorticoid receptor 
MYPT1  myosin light chain phosphatase subunit 1 
Phe   phenylephrine 
PKG-1   cGMP-dependent protein kinase G type 1 
PVAT   perivascular adipose tissue (mesentery) 
ROCK   rho kinase 
ROS   reactive oxygen species 
Sgk-1   serum and glucocorticoid regulated kinase-1 
SNP   sodium nitroprusside  
VSMCs  vascular smooth muscle cells 
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Introduction 
Aldosterone classically acts via the renal epithelial mineralocorticoid receptors (MR) leading 
to salt and volume homeostasis and consequently blood pressure regulation. MR is also expressed in 
non-epithelial cells including cardiomyocytes (1), vascular cells (2, 3) and macrophages (4, 5) and 
have been implicated in pathological conditions such as heart failure, endothelial dysfunction, 
hypertension, insulin resistance and obesity (6-10). Recently, MR has been identified in adipocytes 
(11-14). The (patho)-physiological significance of adipocyte MR is unclear, although experimental 
and human studies have demonstrated increased expression of adipocyte MR in obesity, metabolic 
syndrome and diabetes (6, 14, 15). Adipose tissue has long been considered primarily as a simple fat 
storage of triglycerides to regulate several important functions such as energy balance and 
thermogenesis, but is now recognized as a metabolically active endocrine/paracrine/autocrine organ 
that synthesizes, stores, and secretes hormones, vasoactive factors and proteins, termed 
adipo(cyto)kines (16, 17). MR mediates effects of aldosterone and glucocorticoids, which in 
adipocytes regulate adipogenesis, adipocyte maturation and adipokines production (12, 18-20). We 
recently demonstrated that adipocytes possess functionally active MR and have the machinery to 
produce aldosterone, processes that are increased in obesity-associated diabetes and which influence 
vascular function (6, 12, 13). 
 To better understand the relevance of the adipocyte MR, we generated a conditional 
transgenic mouse model allowing restricted and inducible MR overexpression in an adipocyte-specific 
manner. These mice exhibit features of metabolic syndrome, including weight gain, insulin resistance 
and dyslipidemia, with increased activation of prostaglandin D2 synthase (14). Considering the 
growing evidence that adipose tissue and adipokines influence vascular tone, and that the 
aldosterone/MR system is involved in vascular pathology associated with cardiovascular disease, we 
questioned whether upregulation of adipocyte MR in mice leads to vascular dysfunction.  
Material and Methods 
Generation of mice expressing human MR (hMR) in adipocytes 
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The study was approved by the Animal Ethics Committee of the University of Ottawa. All studies in 
animals were conducted in accordance with the National Institutes of Health Guide for the Care and 
Use of Laboratory Animals. All procedures followed were in accordance with institutional guidelines. 
We generated mice with targeted overexpression of hMR in adipocytes using the conditional 
tetracycline-inducible system as we recently reported (14) and summarized in Supplementary Fig. 1A 
and B. Double-transgenic (‘adipocyte MR over-expression’, Adipo-MROE) mice were obtained by 
mating two strains: the mono-transgenic tetO-hMR mouse and the mono-transgenic transactivator 
aP2-rtTA mouse. In Adipo-MROE mice, hMR expression is switched on in adipocytes by 
administering doxycycline (Dox) (2 g/L for 4 weeks) (200 mg/kg Dox diet, Harlan Laboratories, 
Ontario, Canada). The litters consisting of Adipo-MROE, mono-transgenic tetO-hMR, mono-
transgenic aP2-rtTA, and WT mice were born in the expected mendelian ratio (25% for each 
genotype). The last 3 groups, which displayed no molecular or functional differences between them, 
were considered as controls (Control-MR). Blood pressure was measured by the tail-cuff method in 2-
3 month-old mice. Mice were sacrificed to recover mesenteric arteries and adipose tissues used for the 
subsequent manipulations of cell culture, histology or bio-molecular analysis.  
Isolation and culture of mature adipocytes from mouse adipose tissue 
Mouse mature adipocytes 
Mouse abdominal epididymal visceral adipose tissue (EVAT) was obtained from 4 month-old male 
Adipo-MROE and their littermates Control-MR mice. Mature adipocytes fraction was isolated and 
cultured at 37°C for 24 hrs as previously described (12).  
Conditioned culture medium 
The conditioned culture medium, collected from mature adipocytes (ACM) 24 hrs after isolation 
(12,21), was concentrated in speed vacuum system (Vacufuge Eppendorf) and kept at -20ºC for 
further aldosterone, corticosterone, angiotensin II and hydrogen peroxide levels determinations.  
Vascular studies 
Second order branches of mesenteric artery without perivascular fat (PVAT) were isolated from 3- 4 
month-old Adipo-MROE and their littermates Control-MR mice and mounted on a wire myograph 
(DMT myograph, ADInstruments Ltd, Oxford, UK) as previously described (13). Endothelium-
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dependent and -independent relaxations were assessed by measuring dilatory responses to 
acetylcholine (ACh, 10-9 to 10-5 mol/L) and sodium nitroprusside (SNP, 10-9 to 10-5 mol/L), 
respectively, in arteries pre-contracted with phenylephrine (Phe) to similar degrees to achieve 
approximately 80% of maximal response. Dose-response curves for insulin-induced relaxation (10-10 
to 10-5 mol/L) were also obtained in arteries with intact endothelium in absence or in presence of a 
general ROS scavenger, N-Acetyl-cysteine (10-6M) or a H2O2 scavenger, PEG-catalase (100 U/mL) 
incubated 30 minutes prior to pre-contraction with Phe. Contraction curves to cumulative increasing 
doses of Phe, noradrenaline (NA) and serotonin (5-HT, 5-hydroxytryptamine) (10-9 to 10-5 mol/L) 
were performed in arteries with and without intact endothelium. 
Healthy PVAT and other fat depots display a protective anticontractile effect on the vasculature that is 
lost in obesity.  This anticontractile property remained with the transfer of the culture bath to vessels 
without adipose tissue and suggested the action of secreted relaxing substances. In that way, we 
investigated the effects of visceral fat using ACM (from EVAT) from Control-MR and Adipo-MROE 
mice on contractile responses to Phe. A small piece of EVAT is incubated in 10 mL of Krebs solution 
30 min prior to concentration-response curve to Phe. It has been suggested that PVAT behaves 
similarly to visceral fat in terms of secretion of vasoactive factors (22). We also evaluated the effects 
of a specific inhibitor of Protein Kinase G type-1 (PKG-1) on vascular reactivity. Arteries were pre-
treated with Rp-8-Br-PET-cGMPS (3x10-5 mol/L) or vehicle (DMSO) for 30 min before exposing 
vessels to Phe (endothelium-denuded mesenteric arteries) or hydrogen peroxide (H2O2, 10
-6 to 10-3 
mol/L) (endothelium-intact arteries).  
Arterial stiffness was studied with a pressure myograph (Living Systems, Burlington, Vermont) as 
previously described (13). The artery was set to an internal pressure of 45 mmHg, pressure-fixed (30 
min, 10% formalin, 37°C) and stored embedded in paraffin until histomorphometry studies. Vascular 
structure and mechanical parameters were calculated as previously described (13). 
Elastin content assessment by Elastic Van Gieson 
Deparaffinized Sections (5 µm) were rehydrated in sequential alcohol baths and washed in distilled 
water.  For elastin content, tissue sections were stained with Miller’s Elastin (VWR, Cat. #351154S) 
and Van Gieson solutions (Sigma Aldrich, Cat. # HT25A). Elastic fibers and mast cell granules are 
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stained black/purple, collagen in red and cytoplasm and muscle in yellow. Mesenteric arteries were 
visualized under an Axio Observer-Z1 Zeiss microscope and captured with a colour camera under 
identical conditions of light intensity and exposure time settings. For all sections, total area and area 
of elastin content were measured on calibrated images at x40 magnification using Image J software. 
All data are presented as mean percentage of elastin content ± SE of 9 mice per group.   
Cell culture of mouse vascular smooth muscle cells 
To interrogate some molecular mechanisms underlying altered vascular function in Adipo-MROE 
mice, we also studied cultured VSMCs (passages 4 to 6) from control mice (C57/Bl6 mice), from 
mesenteric arteries as described in detail previously (12). VSMCs were stimulated with H2O2 (10
-6 to 
10-3 mol/L) for 24 hrs to recapitulate vascular oxidative stress observed in Adipo-MROE mice. In a 
second set of experiments, VSMCs were incubated with PEG-catalase (1000 U/mL) or the PKG-1 
antagonist (DT-3, 10-8 mol/L) for 30 min and then stimulated with 10-3 mol/L H2O2 for 24 hrs. 
Concentrations of antagonists used, which effectively inhibited respective receptors, were based on 
preliminary dose-response studies (data not shown). 
Both inhibitors DT-3 and Rp-8-Br-PET-cGMPS used in our studies are highly potent, permeable and 
selective for protein kinase G type-1α, and reduced cGMP-stimulated PKG activity (23). 
Enzymatic immunoassays 
Aldosterone, corticosterone and angiotensin II measurements 
Aldosterone (#10004377), corticosterone (#500651) and angiotensin II (#A05880) concentrations 
were determined in plasma and ACM from cultured adipocytes from Adipo-MROE and Control-MR 
mice by enzyme immunoassay (EIA) (Cayman Chemical, Ann Arbor, MI, USA) according to the 
manufacturer´s instructions. Standard curves were derived using non-conditioned medium and blank 
measurement of non-conditioned medium was subtracted from all samples. Blood samples were 
collected into heparinized tubes, centrifuged at 2000 g at 4ºC for 10 min and plasma was further 
stored at -80ºC until analysis.  
Rho Kinase Activity 
Enzymatic activity of Rho kinase was evaluated using a Rho-associated Protein Kinase (ROCK) 
Activity Assay Kit (Merck Millipore #CSA001, United Kingdom) and the experiments were 
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performed in mesenteric arteries and aortic protein lysates, according to the manufacturer’s 
instructions. 
Amplex Red Assay 
The Amplex Red assay (Invitrogen, Life technologies, Paisley, United Kingdom), involves 
measurement of H2O2 by the horseradish peroxidase–catalyzed oxidation of the colorless and non-
fluorescent molecule N-acetyl-3, 7-dihydroxyphenoxazine (Amplex Red) to resorufin which, when 
excited at 530 nm, strongly emits light at 590 nm. The assay was performed in vessels and adipose 
tissues from Adipo-MROE and Control-MR mice according to the manufacturer’s instructions. 
Phosphorylation of insulin receptor substrate 1 (IRS1) 
Phosphorylation of IRS1 at the serine-307 was evaluated using an ELISA kit (Merck Millipore #17-
459, United Kingdom) and the experiments were performed in mesenteric arteries protein lysates, 
according to the manufacturer’s instructions. Serine-307 phosphorylation of insulin receptor substrate 
1 (IRS1) has been shown to mediate insulin resistance (24-26).  
Western blot analysis  
Mesenteric arteries, aorta from Adipo-MROE and Control-MR mice and VSMCs were prepared and 
western blotting analysis was performed as previously described (12). Antibodies were as follows: 
anti-Phospho-MYPT1 (Thr-696) (1:1000, #sc-17556, Santa Cruz Biotechnology, CA, USA), anti-
MYPT1 (H-130) (1:1000, #sc-25618), anti-Phospho-ezrin (Thr-567)-radixin (Thr-564)-moesin (Thr-
558) (p-ERM, 1:1000, #3142, Cell Signaling, USA) and anti-ERM (1:1000, #3142), anti-Phospho-
MLC 2 (Thr18/Ser19) (1:1000, #3674, Cell Signaling, USA) and anti-MLC (1:1000, #3672), anti-
Phospho-eNOS (Ser-1177) (1:1000, #9571, Cell Signaling, USA), anti-eNOS (1:1000, #9572), anti-
Rho kinase type 2 (ROCK2, 1:1000, #8236, Cell Signaling, USA), anti-RhoA (26C4) (1:500, #sc-418, 
Santa Cruz Biotechnology), anti-PKG-1 (1:1000, 3248, Cell Signaling, USA). Blots were analyzed 
densitometrically using the Image J software. 
Quantitative real time Polymerase Chain Reaction  
Total RNA was extracted from mature adipocytes, EVAT, PVAT and mesenteric arteries as 
previously described (13, 14). Real time PCR was carried out on a 7900HT Fast Real-Time PCR 
machine (Applied Biosystems) using gene-specific primers to quantify the relative abundance with 
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SYBR Green I as the fluorescent molecule. The primers were designed using the software Primer 3 
and are listed in Supplementary Table 1. Ubiquitin C (Ubc) housekeeping gene was used as the 
reference gene for normalization. The relative copies number of the target genes were calculated with 
the 2(-∆∆Ct) method, after assessment that PCR efficiency was 100%.  
Drugs and solutions 
ACh, SNP, Phe, IBMX, insulin, dexamethasone, hydrogen peroxide, N-Acetyl-cysteine and PEG-
catalase were obtained from Sigma-Aldrich Ltd (Dorset, United Kingdom). DT-3 was obtained from 
Merck Millipore (Calbiochem Ltd, United Kingdom). Rp-8-Br-PET-cGMPS was obtained from 
Tocris (Canada). Dexamethasone was dissolved in 100% ethanol. IBMX was dissolved in 0.35N 
KOH. ACh, SNP, Phe, H2O2, N-Acetyl-cysteine and insulin were dissolved in distilled water. DT-3, 
PEG-catalase and Rp-8-Br-PET-cGMPS were dissolved in DMSO. 
Data Analysis 
Values reported are means ± SE. Differences between groups were assessed with the nonparametric 
Mann-Whitney test. Vascular reactivity results were assessed with one and two-ways ANOVA with 
repeated measures, followed by Bonferroni multiple comparison test, as appropriate. Morphometry 
analysis were assessed with one-way ANOVA. An independent two tailed t-test  assuming equal 
variances was used for comparing the mean percentage of elastin content between the different 
groups. Values of p<0.05 were considered significant. 
Results 
Conditional MR overexpression in adipocytes in mice. 
As previously described (14), conditional MR overexpression for 4 weeks leads to a 3-4 fold increase 
in MR expression in mature adipocytes isolated from epididymal visceral adipose tissue (EVAT) from 
Adipo-MROE mice compared to adipocytes from littermate Control-MR mice (Supplementary Fig. 
2A). MR expression is increased in whole EVAT, as well as in PVAT around the mesentery but not in 
mesenteric arteries (Supplementary Table 2). Gene expression of a known downstream target of 
aldosterone/MR activation, serum and glucocorticoid regulated kinase-1 (Sgk1) was increased 3-fold 
in adipocytes from Adipo-MROE versus Control-MR mice, whereas it is not changed in mesenteric 
arteries (Supplementary Fig. 2B) indicating that hMR is functionally active and its activation is 
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increased in Adipo-MROE mice. Supplementary Table 3 summarizes the general characteristics of the 
Control-MR and Adipo-MROE mice. Systolic blood pressure and heart rate were similar between 
Adipo-MROE and Control-MR mice. Body weight was increased by 21.4% in Adipo-MROE mice. 
Heart and kidney weights relative to tibia length were comparable between both groups, whereas 
EVAT weight relative to tibia length was increased by 21.7% in Adipo-MROE mice. Plasma levels of 
aldosterone, corticosterone, and angiotensin II were similar between Adipo-MROE and Control-MR 
mice. Levels of these hormones in adipocyte culture conditioned medium were also similar between 
both groups (Table 1). 
Endothelial function and vascular contractility in Adipo-MROE mice.  
Vasodilatory responses. 
Acetylcholine (ACh)- and insulin- induced vasorelaxation was assessed in mesenteric arteries from 
Adipo-MROE and Control-MR mice. ACh-induced vasorelaxation, indicative of endothelium-
dependent vasodilation, was similar between both groups, as well as for SNP-induced vasorelaxation 
(indicative of endothelium-independent vasodilation) (Supplementary Fig. 3A and B). However, the 
ability of insulin to cause dose-dependent vasorelaxation was significantly impaired in vascular 
segments from Adipo-MROE mice than those from Control-MR littermates (15.7±4.4% versus 
30.3±8.3% to 10-6 mol/L insulin; p<0.05), indicating an impaired insulin sensitivity in vessels from 
Adipo-MROE mice (Supplementary Fig. 3C). However, this was improved ex vivo by both inhibitors 
of reactive oxygen species (ROS), N-Acetyl-cysteine or PEG-catalase (Supplementary Fig. 3D). 
These results were confirmed with increased phosphorylation of insulin receptor substrate 1 (IRS1) at 
serine 307 (+154% from Control-MR) (Supplementary Fig. 3E). IRS1 phosphorylation at serine-307 
has been highlighted as a molecular event that causes insulin resistance (25, 26). Thus, Adipo-MROE 
mice displayed vascular insulin resistance. 
Contractile responses. 
Maximum responses to high concentration of potassium chloride (KCl) are identical between Control-
MR and Adipo-MROE mice (response to KCl: Control-MR, 2.2±0.1 vs Adipo-MROE, 2.1±0.2 
mN/mm; n=10 mice per group, ns) (Supplementary Fig. 4A). Phe-induced contraction of arteries with 
intact endothelium was significantly reduced in Adipo-MROE mice versus control counterparts (Fig. 
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1A). Similar contractile alterations were observed in Adipo-MROE mice in response to increasing 
doses of NA and 5-HT in which the endothelium had been mechanically denuded (Figure 1B and 
Supplementary Fig. 4B and C). The difference in contractile responses between the experimental and 
control groups was greater when the endothelium was denuded (Phe 10-5M, mN/mm: Control-MR 
+endothelium, 2.5±0.2; Adipo-MROE +endothelium, 2.0±0.1, ∆ =0.5; Control-MR -endothelium, 
2.7±0.2; Adipo-MROE -endothelium, 1.7±0.3, ∆ =1.0; n=8-10 mice per group, p<0.05). 
Experimental evidences support a pathological effect of PVAT on the vasculature with increasing 
adiposity. To test if this is the case in our conditional model that displays visceral adiposity, we 
examined the effect of adipose tissue-secreted factors using mouse ACM (from EVAT) on 
contractility of mesenteric arteries of either Control-MR either Adipo-MROE mice. In both Control-
MR and Adipo-MROE, ACM from Control-MR mice decreases contractile responses to Phe, but not 
the ACM from Adipo-MROE mice (Fig. 1C and D), suggesting that ACM from Adipo-MROE lose its 
anticontractile effect. Interestingly, ACM from Adipo-MROE mice increases contractility in arteries 
of Control-MR by secreting possibly vasoconstrictor factors which influence vascular tone in a 
paracrine way (Fig. 1C). 
Adipocyte-specific MR over-expression is associated with down-regulation of vascular Rho 
kinase signaling. 
Small GTPases of the Rho family influence vascular tone primarily by regulating VSMC contraction. 
Considering the significant alteration of vascular contractility in Adipo-MROE mice, we explored the 
possibility that RhoA/ROCK may be involved. ROCK activity was significantly reduced in 
mesenteric arteries from Adipo-MROE versus Control-MR mice (% Control-MR: 100±12.9 vs 
41±7.5, n=7 mice per group, p<0.01). This was associated with decreased phosphorylation of 
downstream targets of ROCK signaling, specifically: the myosin phosphatase subunit 1 (MYPT1) 
(Fig. 2A), the ezrin-radixin-moesin (ERM) (proteins linking the actin cytoskeleton with the plasma 
membrane) (Fig. 2B) and the myosin light chain (MLC) (Fig. 2C).  
Protein levels of RhoA and ROCK isoform 2 (ROCK2) were similar in experimental and control 
groups (Supplementary Fig. 5A). To evaluate whether contractile alterations relate to endothelial 
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nitric oxide synthase (eNOS), we assessed phosphorylation status of eNOS on the active site, Serine-
1177, which was not significantly different in Adipo-MROE and control groups (Supplementary Fig. 
5B).  
Adipocyte-specific MR over-expression is associated with activation of cGMP-dependent 
protein kinase G type 1 (PKG-1) and increased levels of vascular reactive oxygen species 
production. 
To investigate molecular mechanisms involved in decreased vascular ROCK activity in mice with 
adipocytes-targeted MR overexpression, we focused on cyclic GMP-dependent kinase G (PKG)-1, 
which is activated by ROS such as H2O2 in VSMCs, and which has been shown to attenuate 
vasoconstriction and promote vasodilation (27, 28). As shown in Fig. 3A, expression of PKG-1 was 
significantly higher in arteries from Adipo-MROE mice compared with controls. To explore potential 
molecular mechanisms whereby PKG-1 is activated, we focused on diffusible factors such as H2O2 
that are involved in regulation of vascular tone. Production of H2O2 in ACM from mature adipocytes 
(EVAT) of Adipo-MROE mice showed a 2.8-fold increase versus Control-MR mice, as well as in 
extracts from EVAT (2.3 fold increase) (Fig. 3B). The accumulation of H2O2 in adipose tissue is 
supported by the 2.5 fold-decrease in catalase mRNA levels in EVAT from Adipo-MROE mice 
(Control-MR, 1.3±0.2 vs Adipo-MROE, 0.52±0.05, arbitrary units; n=6 mice per group, p<0.01), 
whereas Sod (superoxide dismutase) mRNA levels were unchanged (Control-MR, 0.9±0.1 vs Adipo-
MROE, 1.22±0.2, arbitrary units; n=6 mice per group, ns). Moreover, we evaluated the mRNA levels 
of NADPH oxidase (Nox) isoforms 1, 2 and 4 to define the source of ROS. Interestingly Nox-4 
mRNA levels are increased whereas Nox-1 and Nox-2 are unchanged in adipose tissues from Adipo-
MROE mice (Supplementary Fig. 6A and B). Thus, increased generation of H2O2 by adipocytes of 
Adipo-MROE mice may influence vascular contractility of Adipo-MROE mice and the RhoA/ROCK 
system through PKG-1 activation.  
Exogenous hydrogen peroxide leads to down-regulation of ROCK activity. 
To understand the mechanistic basis of the relationship between PKG-1 and ROCK activity in 
VSMCs exposed to oxidative stress conditions, we examined ROCK activity in primary cultured 
mouse VSMCs exposed to exogenous H2O2. H2O2 dose-dependently increased expression of PKG-1 
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(Fig. 4A). We next analyzed the effect of H2O2 on ROCK activity in the absence and presence of a 
specific inhibitor of PKG-1 (DT-3) or an antioxidant, PEG-catalase. Exogenous H2O2 induced a 
significant decrease in ROCK activity (Fig. 4B) and its downstream signaling (Fig. 4C). This response 
was reversed when cells were pre-treated with DT-3 and PEG-Catalase (Fig. 4B), indicating that H2O2 
is a negative regulator of ROCK activation through processes that involve PKG-1.  
PKG-1 inhibition restores normal contraction in Adipo-MROE mice. 
To analyze whether modulating PKG-1 expression affects vascular functional responses, we analyzed 
contractile responses in the presence of Rp-8-Br-PET-cGMPS, a specific inhibitor of PKG-1. Phe-
induced vasoconstriction in endothelium-denuded arteries from Adipo-MROE was comparable with 
Control-MR mice when PKG-1 was inhibited (Fig. 5A). Endothelium-dependent relaxation induced 
by H2O2 after PKG-1 inhibition was similar in arteries between Adipo-MROE and Control-MR mice 
(Fig. 5B).  
Elasticity and elastin content are increased in mesenteric arteries from Adipo-MROE mice. 
To evaluate potential factors contributing to vascular hypocontractility in Adipo-MROE mice, we 
examined elasticity and elastin status of mesenteric arteries from the different groups. As shown in 
Supplementary Fig. 7A, the stress-strain relationship curve was shifted to the right, indicating that the 
mesenteric arteries from Adipo-MROE mice are more elastic than the Control-MR mice. 
Using Elastic Van Gieson stain we show that elastin content was higher, as assessed qualitatively and 
semi-quantitatively, in mesenteric arteries from Adipo-MROE mice compared to the Control-MR 
mice (Supplementary Fig. 7B, 7C). This is further supported by upregulation of elastin mRNA levels 
in mesenteric arteries from Adipo-MROE mice compared to the Control-MR mice (Supplementary 
Fig. 7D). 
Upregulation of ACE2/Ang (1-7)/Mas system in Adipo-MROE mice. 
Another molecular mechanism that could be involved in the hypocontractility is the counter-
regulatory pathway of the renin-angiotensin-aldosterone system, the ACE2/Ang (1-7)/Mas receptor 
system, which has been reported to contribute to visceral obesity (29-31). Ace2 and Mrga (Mas 
receptor) mRNA levels were upregulated in EVAT of Adipo-MROE mice by 5-fold and 2-fold 
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respectively. Moreover, Mrga transcripts levels were increased in mesenteric arteries of Adipo-
MROE mice, but not Ace2 (Supplementary Table 4).  
Pro-inflammatory phenotype in adipose tissue from Adipo-MROE mice. 
Insulin resistance and visceral obesity are commonly associated with chronic, low-grade 
inflammatory state. Thus the mechanisms whereby adipose tissue causes alterations in insulin 
sensitivity could include the secretion of pro-inflammatory factors by the adipose tissue. Moreover, 
these adipo(cyto)kines and chemokines would also represent candidates/mediators through which 
adipose tissue can modulate vascular function.  
We evaluated by real time PCR mRNA levels of specific markers of macrophages: in EVAT and 
PVAT from Adipo-MROE mice vs Control-MR mice, levels of transcripts of F4/80 and Cd-68 are 
about 2 fold-increased suggesting that adipose tissues from Adipo-MROE contains more 
macrophages. We then assessed the two activation states of macrophages: M1 (pro-inflammatory, e.g 
IL-6, IL-12, MCP-1 (monocyte chemotactic protein-1), Tnf-α (tumor necrosis factor-α), Rantes) and 
M2 (anti-inflammatory e.g adiponectin, IL-10, Cd-206 (mannose receptor)). Interestingly, in EVAT 
and PVAT from Adipo-MROE some pro-inflammatory markers mRNA levels (Il-6, Mcp-1 and 
Rantes) are increased, whereas mRNA levels of anti-inflammatory markers are decreased 
(Adiponectin and Cd-206).  Results are summarized in Supplementary Tables 5.  
Discussion 
We previously demonstrated that MR over-activation specifically in adipocytes leads to 
significant metabolic abnormalities including increased visceral adiposity, insulin resistance, and 
dyslipidemia (14). Here, we examined the potential vascular comorbidities that might accompany 
these metabolic alterations. These studies were prompted by our previous findings where we 
demonstrated that increased expression of adipocyte MR in obese diabetic mice and humans was 
associated with vascular dysfunction (13) but a causal relationship was not established. Using mice 
that conditionally overexpress MR in an adipocyte-specific manner, we found that vascular 
contractility was markedly reduced, whereas endothelial function was normal. These phenomena were 
associated with increased H2O2 generation by adipocytes leading to upregulation of redox-sensitive 
PKG-1 and downregulation of vascular ROCK (Fig. 6). Adipose tissue from Adipo-MROE lost its 
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anticontractile properties possibly by increasing secretion of contractile factors, as evidenced by our 
experiments with ACM on contractility of healthy arteries of Control-MR. Serine-307 
phosphorylation of IRS1 has been highlighted as a molecular event that causes insulin resistance (24, 
26). In our studies, the increase in phosphorylation IRS1 at serine-307 confirms the insulin resistant 
phenotype of the Adipo-MROE mice. Together these findings indicate that upregulation of adipocyte 
MR has significant impact, not only on metabolic parameters, but also on vascular function. 
Increasing evidence supports a role for adipocyte MR over-activation in pathophysiological 
conditions associated with metabolic disorders and cardiovascular diseases. For example, 1) there is 
increased expression and activation of MR in adipose tissue in experimental and human obesity, 
diabetes, and cardiovascular diseases (6, 14, 15, 32); 2) MR antagonism with eplerenone or 
spironolactone improves metabolic disorders and insulin resistance in obese and diabetic mice (9, 18, 
19, 33); 3) Adipo-MROE mice exhibit features of metabolic syndrome (14); and 4) MR antagonism in 
obese mice improves vascular function (10,13). Here we further support this thesis by showing that 
increased activation of adipocyte-specific MR influences functional properties of arteries. The 
vascular phenotype identified in Adipo-MROE mice (which are obese and have features of metabolic 
syndrome but no hypertension) is unusual in that it shows no apparent endothelial dysfunction but 
exhibits hypocontractility of small arteries. Our transgenic mouse model has some special 
characteristics that differ to other models of obesity, such as the db/db mice. Our model did not 
display global obesity, did not have increased levels of aldosterone, and did not exhibit altered MR 
signaling in the vasculature. They did however show features of hyperelasticity and upregulation of 
the protective axis of the renin-angiotensin-system, namely Ang-(1-7)/Mas, which may explain, in 
part, why the Adipo-MROE mice do not have endothelial dysfunction associated with the weight gain 
and why the vessels are hypocontractile. Other models have also demonstrated hypocontractility of 
vessels in pathological conditions. For example, in portal hypertension, ROS (in particular H2O2) 
levels are increased and vascular contractility is reduced. In Ccl4-induced cirrhotic rats, H2O2 has 
been directly implicated in regulating mesenteric hypocontractility to noradrenaline through Rho 
kinase signaling pathway (34). Another study in splanchnic vessels of patients and rats with cirrhosis 
suggested a role for ACE2/Ang (1-7)/Mas axis to explain the vascular hypocontractility (35). In our 
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study, Ace2 and Mrga (Mas receptor) gene expression were upregulated in EVAT of Adipo-MROE 
mice, supporting other studies which demonstrated hypocontractility (35).  
One of the major signaling pathways regulating vascular smooth muscle contraction is the 
RhoA/ROCK signaling pathway and its downstream targets (36). The contractile state of vascular 
smooth muscle is driven by phosphorylation of the regulatory protein, MLC and reflects the balance 
of the Ca2+-calmodulin-dependent myosin light chain kinase and myosin light chain phosphatase 
(MLCP) activities (37). Phosphorylation of MYPT1 at Thr-696 plays a dominant role in MLCP 
inhibiton and has been shown to be increased in hypertension (38, 39). The ezrin-radixin-moesin 
(ERM) proteins are also downstream targets of RhoA and are involved in cytoskeletal organization. 
We found a significant decrease in ROCK activity and decreased activation of ROCK-dependent 
signaling proteins, including MLC, MYPT1 and ERM in vessels from Adipo-MROE mice. 
Downregulation of vascular RhoA/ROCK signaling may contribute to impaired contractility in an 
endothelium-independent manner as it was previously reported (40-42). This is unusual as well, since 
in the context of metabolic syndrome, obesity or diabetes, animals displayed increase in MR activity 
associated with increased ROCK activity (6, 43, 44). In addition, plasma aldosterone levels are 
increased in obese diabetic human and animals, whereas in Adipo-MROE mice, aldosterone plasma 
levels are unchanged and MR over-activation is restricted to the adipocytes. 
Adipocyte MR over-activation leads to an increase in ROS production by adipocytes, which 
is also evident in adipose tissue from obese mice (45) and humans (46). Functionally, increased H2O2 
has been associated with either vasoconstriction (47-49) or vasodilation (50-52) through activation of 
PKG-1. Activation of vascular PKG-1 was increased in Adipo-MROE mice, which may also impact 
on dysregulated VSMC contractility in these mice. Indeed, pharmacological inhibition of PGK-1 
activity blunted mesenteric hypocontractility in Adipo-MROE mice. Hence, we demonstrated a direct 
role of MR-dependent ROS production by adipocytes on the vasculature. In vitro studies in cultured 
VSMCs indicated that exposure to H2O2 induced significant downregulation of ROCK and increased 
activation of PKG-1 pathways involved in VSMC contraction/dilation. The ex vivo studies 
recapitulated what we observed in Adipo-MROE mice, unravelling a key mechanism underlying the 
crosstalk between adipose tissue and vascular function.  
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Putative mechanisms whereby adipocyte MR-induced H2O2 generation regulates vascular 
function through PKG-1 likely involve cGMP, since PKG-1 regulates nitric oxide synthase (NOS) 
activation and NO production, which in turn activates guanylyl cyclase resulting in elevated cGMP, a 
potent regulator of vascular smooth muscle cell dilation (53). In addition to this classical pathway, 
recent evidence indicates that H2O2 can directly activate cGMP via compound I, which activates 
PKG-1 resulting in changes in activity or function of various serine/threonine proteins (54-56). 
Moreover, H2O2-dependant oxidation/activation of PKG-1 is associated with vasodilation (57). 
Accordingly, a possible link between adipocyte-derived H2O2 and PKG-1-associated changes in 
vascular function may be cGMP.  
In summary, our in vivo study demonstrates that mice with conditional upregulation of 
adipocyte MR, which nave metabolic syndrome and obesity, exhibit impaired vascular contractility 
through processes that involve adipocyte-derived H2O2, which influences vascular redox-sensitive 
PKG-1 and Rho kinase pathways. Mechanisms associated with these vascular changes may relate to 
increased elastin content and upregulation of the protective axis of the renin-angiotensin system. Our 
study further highlights important crosstalk between adipocytes and vascular cells and indicates that 
activation of the adipocyte MR system leads to production of vasoactive adipocyte-derived factors, 
such as H2O2, which may impact on vascular dysfunction in conditions associated with metabolic 
disorders. These novel findings emphasize the functional importance of adipocyte MR in 
cardiovascular complications associated with obesity/adiposity, insulin resistance and metabolic 
syndrome.  
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Table 1. Aldosterone, Corticosterone and Angiotensin II levels in plasma and adipocyte-
conditioned culture media from EVAT from Adipo-MROE and littermate Control-MR mice. 
Values are means ± SE. ACM, adipocyte culture conditioned medium; EVAT, Epididymal visceral 
adipose tissue. 
 
 
 
 
 
 
 
 
 
 
 
Parameters Control-MR (7) Adipo-MROE (10) 
Plasma Aldosterone (pg/mL) 432 ± 45 388 ± 29 
Plasma Corticosterone (ng/mL) 1064 ± 86 1105 ± 84 
Plasma Angiotensin II (pg/mL) 476 ± 59 573.6 ± 70 
Aldosterone in ACM (pg/mL/µg RNA) 272 ± 48 347 ± 96 
Corticosterone in ACM (ng/mL/µg RNA) 2088 ± 378 2297 ± 403 
Angiotensin II in ACM (pg/mL/µg RNA) 852 ± 295 705 ± 217 
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Figures legends. 
Figure 1. Effect of adipocyte conditioned medium on contractility of mesenteric arteries from 
Adipo-MROE and Control-MR mice.  
A and B: Contractile responses to cumulative and increasing doses of phenylephrine (Phe, 10-9 to 10-
5M) in mesenteric arteries with and without intact endothelium were significantly decreased in Adipo-
MROE vs Control-MR mice. C and D: Effect of adipocyte conditioned culture medium (ACM) on 
contractile responses to Phe of arteries from Control-MR mice and from Adipo-MROE mice. For A, 
B, C and D, two-way ANOVA test was performed, followed by Bonferroni test. Data were performed 
in repeated measures and presented as mean ± SE; n=8 to10 mice/group. * p<0.05 Adipo-MROE vs 
Control-MR.  
Figure 2. ROCK signaling in mesenteric arteries from Adipo-MROE and control-MR mice.  
A-C: Downregulation of downstream targets of RhoA/Rho kinase activation. The myosin phosphatase 
subunit 1 (MYPT1) (A), the ezrin, moesin, radixin (ERM) (B) and the myosin light chain (MLC20) 
(C) protein phosphorylations were significantly decreased in mesenteric arteries from Adipo-MROE 
vs Control-MR mice. Western blotting was performed using Mypt1 and P-Mypt1 (Thr696), ERM and 
P-ERM (Thr567, Thr564, Thr558), MLC20 and P-MLC20 (Thr
18/ Ser19) antibodies. Integrated intensities 
were obtained by the Image J software. For A-C: Mann-Whitney nonparametric test was performed. 
Data represent means ± SE; n=10 mice/group. * p<0.05, ** p<0.01, Adipo-MROE vs Control-MR.  
Figure 3. Adipocyte-specific MR overexpression: increased vascular PKG-1 protein levels and 
H2O2 production by adipocytes. A: PKG-1 protein levels are upregulated in mesenteric arteries from 
Adipo-MROE vs Control-MR mice. B: Hydrogen peroxide levels in adipocytes culture medium, as 
well as in EVAT from Adipo-MROE versus Control-MR mice. For A and B: Mann-Whitney 
nonparametric test was performed. Data represent means ± SE; n= 6 to 7 mice/group. * p<0.05, ** 
p<0.01, *** p<0.001, Adipo-MROE vs Control-MR.  
Figure 4. Exogenous H2O2 increases expression of PKG-1 and decreases activity of ROCK in 
mouse VSMCs. A: Dose-Response curve. VSMCs from mouse mesenteric arteries were stimulated 
with hydrogen peroxide 10-6M to 10-3M for 24 hours. B: VSMCs from mouse mesenteric arteries were 
stimulated with H2O2 10
-3M in the absence and presence of a specific PKG-1 inhibitor of or an 
antioxidant, for 24 hrs: ROCK kinase activity in H2O2-stimulated VSMCs. Values are expressed as 
means ± SE. n=8 individual experiments. C: ROCK signaling in VSMCs. Protein levels of a marker 
of ROCK activation, ERM phosphorylation is significantly decreased by hydrogen peroxide 10-3M. 
For A, B and C: one-way ANOVA test was performed, followed by Bonferroni test. Data represent 
means ± SE; n=8 individual experiments. ** p<0.01 vs Vehicle, †† p<0.01 vs H2O2. Antioxidant: 
PEG-catalase, 1000 U/mL; PKG-1 inhibitor: DT-3, 10-8 M. 
Figure 5. Effect of PKG-1 inhibition on vascular reactivity in Adipo-MR mice.  
Contractile and vasodilatory responses of fat-free mesenteric resistant arteries, from Adipo-MROE 
mice and their Control-MR littermates were evaluated using a wire myography. A: Pre-incubation 
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with a specific PKG-1 inhibitor, 30 minutes prior to concentration responses curves to phenylephrine 
(Phe, 10-9 to 10-5M), of endothelium-denuded mesenteric arteries from Adipo-MROE mice, restores 
the contractile responses to levels comparable with Control-MR mice. B: Pre-incubation with a 
specific PKG-1 inhibitor 30 minutes prior to concentration responses curves to H2O2 (10
-6 to 10-3M) 
of mesenteric arteries with intact endothelium has similar effects in relaxant responses between 
Adipo-MROE and Control-MR mice. For A and B: two-way ANOVA test was performed, followed 
by Bonferroni test. Data were performed in repeated measures and presented as mean ± SE; in 
brackets are indicated the number of animals per group. * p<0.05 Adipo-MROE vs Control-MR. 
PKG-1 inhibitor: Rp-8-Br-PET-cGMPS, 3x10-5 M. 
Figure 6. Hypothetical scheme of the signaling mechanisms induced by aldosterone/MR over-
activation in adipocytes. Adipocyte-specific MR over-activation leads to decrease in contractility of 
mesenteric arteries from Adipo-MROE vs Control-MR mice. This may involve down-regulation of 
Rho kinase activity and signaling in arteries through hydrogen peroxide (H2O2)-induced PKG-1 
activation. ROS, reactive oxygen species; Sgk1, serum and glucocorticoid regulated kinase-1. 
 
